MELA Sciences Announces FDA Advisory Panel Votes Positively for MelaFind(R) on Safety, Efficacy and Risk/Benefit Ratio COLLEGE PARK, MD--(Marketwire - November 18, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) today announced that the General and Plastic Surgery Devices Panel appointed by the U.S. Food and Drug...

Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting IRVINGTON, NY--(Marketwire - March 12, 2009) - Electro-Optical Sciences, Inc. (EOS) (NASDAQ: MELA) today announced that additional data on MelaFind®, the company's non-invasive, point-of-care...

Electro-Optical Sciences Announces Positive Top-Line Results From Landmark MelaFind(R) Pivotal Trial IRVINGTON, NY--(Marketwire - February 13, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced positive top-line results of its pivotal trial of MelaFind, a non-invasive,...

Electro-Optical Sciences Announces Participation at the 11th Annual Needham Growth Stock Conference IRVINGTON, NY--(Marketwire - December 31, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a...

Electro-Optical Sciences Provides MelaFind(R) Development Update IRVINGTON, NY--(Marketwire - December 29, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a...